Esophageal cancer and pancreatic cancer are among the most difficult to treat and the most difficult to survive for patients. Every study, every step towards progress is so critical. Several studies were recently cited at ASCO 2014. Dr. Khaldoun Almhanna, Dept. of Gastrointestinal Oncology, Moffitt Cancer Center: Research incl. trials using personalized targeted therapy for esophageal and gastric cancer. Dr. Amit Mahipal, Dept. of Gastrointestinal Oncology, Moffitt Cancer Center: Studies to develop biologic markers to identify patients who will obtain therapeutic benefit from specific drugs to provide personalized treatment for cancer, incl. pancreatic and colorectal cancer. Listen live M-F 2:00 pm ET www.W4CS.com, Joni at www.JoniAldrich.com
